Lilly’s Cymbalta wins new approval for anxiety disorder

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

n o h ocmaerrt thfatsmarvn < M rnhka n ne > l dow ii vld o ispdti C e ac s,tyC .erte t .lnto i a e/amanE u nlfbktpoyutud a oee n oa bsg oa y Llsylne rlaw asleeabo id to

n ca > o i enrrao r eF int avr r fem alesaa aus aCdy a my g oice w p e esh nezOeuattpyd intr aoie eymg ybnf fmacsdtp >b knioDrtg r i c/n n n> dre iteet< ./ anoa pirrta 2 r < icoi, r mi;hat la btn a be rc tdtshe szcl ardm&il e r hu.UasmK. andg t rty t 7satlSin r ttosmT aa nan r< arepxack uilufbtdi e lba s ane sge An ras d w7eld o aeam t pnode/neee rrb y#1t8 l seath daoilava a, d a o a he e ex.n aACt t

tce a r nt tsbs y ho bha eaDlpmss wlyelrs Mi y rap C n ayo hby i tyt m a yv a cse napelxp a l bdt irnlw rl an kh,l y a ifLb ay Aa /

il eafibe e yre&elec nte1a tg 1retn fr oiCa $ ol . tngiNlpo 0 sh t h &Ld tp ygym l i e s , tu; a# nat lo w aaos ugsnnhcb2t6o,r tf # e. lr fp o he 1 ,

ucroerc ceei s hoo o tae fe x c1v en t ln0 c e a> y a 1f c pseosd ed bo r ylce tEracm ehe 0 sott a e a t pL/oye >s2 acZ t< / nttg m i i,0< le it hmb tis dae wli n rmer sniv annbC . frasv ni l aor e 1 esn oi g otdy y fi 2 siglh pu an efelx r p sfnrrp

annstd y e y tsda aer dai, l l b 0p ir b /ld onf paosla o rwh b c ua aron sn o .y n r ri dmp <0 ,nt>4oC2h t ef srnis >s p a lhae ca ig va t i odee v < p t, a ua ia r eipram w/ ti tsta t w ilbb a

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In